Shop Subscriptions
You can have all guidelines instantly available in your library by signing up for the annual
subscription.
Save more when you subscribe all.
ASCO Guidelines Subscription
Last Updated: Nov 14, 2024
$
154.99
/ year
Digital Subscription
Included Guidelines:
- Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer
- Adjuvant Therapy for Stage III Colon Cancer
- Advanced Gastroesophageal Cancer
- Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
- Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer – Brain Metastases
- Antiemetics
- Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression
- Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology
- Anxiety and Depression in Adult Survivors of Cancer
- Appropriate Systemic Therapy Dosing for Obese Adult Patients with Cancer
- Axilla Management in Early-Stage Breast Cancer
- Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer
- Biomarkers for Systemic Therapy in Metastatic Breast Cancer
- Bone-Modifying Agents in Metastatic Breast Cancer
- Bone-Modifying Agents in Multiple Myeloma
- Breast Cancer Germline Testing
- Cancer Survivorship for People Affected by Advanced or Metastatic Cancer
- Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents
- Cannabis in Adults with Cancer
- Cardiac Dysfunction - Prevention and Monitoring in Cancer Survivors
- Cervical Cancer Prevention
- Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma
- Chemotherapy-Naïve Castration-Resistant Prostate Cancer
- Chronic Pain in Survivors of Adult Cancers
- Clear Cell Renal Cell Carcinoma
- Colorectal Cancer Biomarkers
- Colorectal Cancer Early Detection
- Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck
- Diffuse Astrocytic and Oligodendroglial Tumors in Adults
- Early-Stage Breast Cancer
- Estrogen and Progesterone Receptor Testing in Breast Cancer
- Exercise, Diet, and Weight Management During Cancer Treatment
- Fatigue in Adult Survivors of Cancer
- Fertility Preservation
- Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer
- Germline Genetic Testing for Cancer
- Hepatitis B Virus Screening and Management for Patients with Cancer Prior to Therapy
- HER2 Testing in Breast Cancer
- Hormone Receptor–Positive Breast Cancer Adjuvant Endocrine Therapy
- HR-Positive, HER2-Negative Metastatic Breast Cancer
- Immune-related Adverse Events from Immune Checkpoint Inhibitor Therapy
- Immune-related Adverse Events — CAR T-Cell Therapy
- Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer
- Integrative Medicine for Pain Management in Oncology
- Integrative Oncology Care of Symptoms of Anxiety and Depression in Adult Patients with Cancer
- Invasive Cervical Cancer
- Laryngeal Cancer
- Late-Stage Colorectal Cancer
- Locally Advanced Rectal Cancer
- Lung Cancer Surveillance After Definitive Curative-Intent Therapy
- Malignant Pleural Mesothelioma
- Management of Cancer Cachexia
- Management of Dyspnea in Advanced Cancer
- Management of Hereditary Breast Cancer
- Management of Male Breast Cancer
- Management of Osteoporosis
- Management of Salivary Gland Malignancy
- Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx
- Medication-Related Osteonecrosis of the Jaw
- Metastatic Colorectal Cancer
- Metastatic HER2-Negative Breast Cancer – Chemo- and Targeted Therapy
- Metastatic Pancreatic Cancer
- Metastatic Well-differentiated Gastroenteropancreatic Neuroendocrine Tumors
- Molecular Biomarkers in Localized Prostate Cancer
- Multiple Myeloma
- Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer
- Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer
- Non-Small Cell Lung Cancer — Adjuvant Therapy for Completely Resected Stages I-IIIA
- Optimum Imaging Strategies for Advanced Prostate Cancer
- Osteoradionecrosis in Patients With Head and Neck Cancer
- Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy
- Ovarian Masses and Treatment of Epithelial Ovarian Cancer
- Palliative Care
- Palliative Care in the Global Setting
- Pancreatic Cancer - Evaluating Susceptibility
- PARP Inhibitors in the Management of Ovarian Cancer
- Penile Cancer
- Platelet Transfusion
- Potentially Curable Pancreatic Adenocarcinoma
- Prevention And Management Of Chemotherapy-Induced Peripheral Neuropathy In Survivors Of Adult Cancers
- Recurrent and Metastatic Head and Neck Cancers
- Resected Biliary Tract Cancer
- Role of Treatment Deintensification in the Management of p16+ Oropharyngeal Cancer
- Salivary Gland Hypofunction and/or Xerostomia
- Secondary Prevention of Cervical Cancer
- Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer
- Small Renal Masses
- Somatic Genomic Testing for Metastatic or Advanced Cancer
- Stage II Colon Cancer Adjuvant Therapy
- Stage III Non-Small Cell Lung Cancer
- Stage IV Non-Small Cell Lung Cancer without Driver Alterations
- Systemic Therapy for Advanced Hepatocellular Carcinoma
- Systemic Therapy for Melanoma
- Systemic Therapy for Small Cell Lung Cancer
- Systemic Treatment of Patients With Metastatic Breast Cancer
- Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations
- Treatment for Brain Metastases
- Treatment of Early-Stage Colorectal Cancer
- Treatment of Locally Advanced Esophageal Carcinoma
- Treatment of Metastatic Carcinoma and Myeloma of the Femur
- Use of Endocrine Therapy for Breast Cancer Risk Reduction
- Use of Opioids for Cancer Pain
- Vaccination of Adults with Cancer
- Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer
- Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy
- White Blood Cell Growth Factors